Three different therapies to target PCSK9
Nat Rev Cardiol
.
2021 Aug;18(8):541.
doi: 10.1038/s41569-021-00581-w.
Author
Andrew Robson
1
Affiliation
1
Nature Reviews Cardiology, . nrcardio@nature.com.
PMID:
34089000
DOI:
10.1038/s41569-021-00581-w
No abstract available
Publication types
Comment
MeSH terms
Anticholesteremic Agents* / therapeutic use
Cholesterol, LDL
Humans
Proprotein Convertase 9*
Substances
Anticholesteremic Agents
Cholesterol, LDL
PCSK9 protein, human
Proprotein Convertase 9